News Articles and Montana BioScience Alliance Newsletters
University of Montana researchers and their partners have found a new method to generate human cartilage of the head and neck.
Microbion Corporation today announced that the company has published results from its topical pravibismane Phase 1b study in the peer-reviewed International Wound Journal.
A message from Scott Whittenburg, UM Vice President for Research and Creative Scholarship: “I’m happy to report that the research enterprise at UM continues to grow.”
Montana State University will send 17 students to one of the country’s premier celebrations of undergraduate research next week, where they will have the opportunity to present the research they have done in departments across the university. The National Conference on Undergraduate Research, or NCUR, will be held April 8-10 in Long Beach, California, and will feature undergraduate researchers from institutions nationwide.
The Montana BioScience Alliance and industry partners are proud to announce the successful 2024 Immersion Day at Rocky Vista University and both local hospitals, the Billings Clinic and Intermountain Health, on February 23, 2024. The Immersion Day follows the Careers in Healthcare Student Summit, hosted at Montana State University Billings, on October 27, 2023.
Drug makers have been racing at a breakneck pace to develop respiratory syncytial virus (RSV) vaccines this year. On May 3, the U.S. Food and Drug Administration (FDA) announced it has approved Arexvy, the first-ever RSV vaccine for individuals 60 and over.
Information on Small Business Funding Webinar, National Small Business Week, America’s SEED Fund Week — and more
SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. The next deadline is April 5. Omnibus Solicitations. Researcher-initiated ideas are proposed via the SBIR and STTR Omnibus grant solicitations. These FOAs do not specify a topic, though they link to identified topics of interest for each participating awarding component. Most small business applications to NIH are submitted to the Omnibus solicitations. Specific Funding […]
FDA advisers endorsed the safety and efficacy of GSK’s respiratory syncytial virus (RSV) vaccine in older adults, setting up a final mad dash with Pfizer as both companies eye the regulatory finish line with their promising new vaccines.
Researchers from Diaceutics and the Personalized Medicine Coalition has published a special report in JCO Precision Oncology that provides an in-depth look at United States health systems’ efforts to deploy potentially paradigm-shifting targeted and immuno-oncology drugs to improve care for lung cancer patients.
View the Winter II 2024 Newsletter now!
View the Winter 2023 Newsletter now!